Aspen in talks to make and sell J&J vaccines for Africa
Africa aims to vaccinate 60% of its adult population by 2022
05 September 2021 - 00:09
Aspen Pharmacare says it is in talks to make Johnson & Johnson's coronavirus shot under licence in SA, at what would be Africa's first major independent distribution base for a global vaccine against Covid-19...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
There’s never been a more important time to support independent media.
From World War 1 to present-day cosmopolitan South Africa and beyond, the Sunday Times has been a pillar in covering the stories that matter to you.
For just R80 you can become a premium member (digital access) and support a publication that has played an important political and social role in South Africa for over a century of Sundays. You can cancel anytime.
Already subscribed? Sign in below.
Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.